Abstract:In most immune responses including transplant rejection, T effector cells always outnumber and outperform Tregs, and therefore means to deplete T effector cells is critical to tolerance induction. T cell apoptosis is known to be permissive to allograft tolerance, but how apoptosis of T effector cells (when and by what degree) affects the induction of Tregs in allograft tolerance remains incompletely defined. In the present study we addressed the interplay of T effector cells and Tregs both in vitro and in vivo and how such interplay impacts transplant tolerance. We found in an in vitro system that activation of T effector cells led to rapid production and consumption of IL-2, which resulted in robust effector cell proliferation in an autocrine fashion. However, presence of Foxp3+Tregs in the same culture allowed CD4+ T effector cells to produce IL-2 but unable to consume IL-2 (lack of STAT5 phosphorylation), and Tregs became the sole cell type in the culture that could use IL-2 in a paracrine fashion (strong STAT5 phosphorylation). In this setting, survival and expansion of Tregs is dependent on survival of IL-2 producing T effector cells, and the degree of Treg proliferation is contingent on levels of IL-2 from T effector cells. Strikingly, addition of Rapamycin in the culture readily induced apoptotic cell death of T effector cells, which resulted in subsequent death of Tregs due to cessation of IL-2 production (death by starvation). Interestingly, inclusion of IL-15 failed to rescue Tregs in spite of the finding that IL-15 also triggered STAT5 activation. Thus, early and massive apoptosis of T effector cells antagonized Tregs unless exogenous IL-2 is provided. In a skin transplant model, we found that Rapamycin alone showed minimal effects in prolonging skin allograft survival, but Rapamycin and IL-2 together markedly extended skin allograft survival (>40 days). Our data demonstrated new mechanistic insights on the interdependence and antagonistic effects of Tregs and T effector cells, and uncovered new aspects where IL-2 works the best in tolerance induction. These new findings may have important clinical implications.

Targeted depletion of PD-1–expressing cells induces immune tolerance through peripheral clonal deletion

Gut Microbes Enlarged the Protective Effect of Transplanted Regulatory B Cells on Rejection of Cardiac Allografts.

Tolerance Induced by IL-6 Deficient Donor Heart is Significantly Involved in Myeloid-Derived Suppressor Cells (Mdscs).

Regulatory T Cell Therapy for the Induction of Clinical Organ Transplantation Tolerance

Homeostatic proliferation is a barrier to transplantation tolerance.

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Prevention of Allograft Rejection by in Vitro Generated Tolerogenic Dendritic Cells

Regulatory T cells and transplantation tolerance.

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance

Tolerogenic Dendritic Cells Transferring Hyporesponsiveness and Synergizing T Regulatory Cells in Transplant Tolerance

Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance.

Inhibitory Feedback Loop Between Tolerogenic Dendritic Cells and Regulatory T Cells in Transplant Tolerance

CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance.

Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells.

Suppression of Allograft Rejection by Cd8+Cd122+Pd-1+Tregs is Dictated by Their Fas Ligand-Initiated Killing of Effector T Cells Versus Fas-Mediated Own Apoptosis

Variegated levels of alloreactive T cell dysfunction in transplantation tolerance determine graft vulnerability to infection-triggered rejection

Program Death-1 Regulates Peripheral T Cell Tolerance Via an Anergy-Independent Mechanism

New Insights on T Cell Apoptosis in the Induction of Treg-Dependent Dominant Tolerance

Overexpression of Programmed Death Ligand 1 in Dendritic Cells Inhibits Allogeneic Lymphocyte Activation in Mice

Expression of PD-1 on T Cells in Allo-Recipients and Its Significance

Nanoparticles loaded with IL-2 and TGF-β promote transplantation tolerance to alloantigen